These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24892516)

  • 1. Practical treatment of Helicobacter pylori: a balanced view in changing times.
    Smith SM; Haider RB; O'Connor H; McNamara D; O'Morain C
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):819-25. PubMed ID: 24892516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Aspects in Choosing a Helicobacter pylori Therapy.
    Molina-Infante J; Shiotani A
    Gastroenterol Clin North Am; 2015 Sep; 44(3):519-35. PubMed ID: 26314666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori - 2012].
    Buzás GM
    Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy.
    Hsu PI; Chen WC; Tsay FW; Shih CA; Kao SS; Wang HM; Yu HC; Lai KH; Tseng HH; Peng NJ; Chen A; Kuo CH; Wu DC;
    Helicobacter; 2014 Feb; 19(1):74-9. PubMed ID: 24033865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori treatment: Still a work in progress.
    Senatore FJ; Wilmot J; Birk JW
    Postgrad Med; 2016 Jan; 128(1):152-7. PubMed ID: 26490697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of Helicobacter pylori: recent advances in treatment.
    McLoughlin RM; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2005 Aug; 19(4):421-7. PubMed ID: 16011728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
    Marin AC; McNicholl AG; Gisbert JP
    Expert Opin Pharmacother; 2013 May; 14(7):843-61. PubMed ID: 23537368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection.
    Venerito M; Krieger T; Ecker T; Leandro G; Malfertheiner P
    Digestion; 2013; 88(1):33-45. PubMed ID: 23880479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for treatment of Helicobacter pylori in the East and West.
    Selgrad M; Bornschein J; Malfertheiner P
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):581-8. PubMed ID: 21819326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.
    Xin Y; Manson J; Govan L; Harbour R; Bennison J; Watson E; Wu O
    BMC Gastroenterol; 2016 Jul; 16(1):80. PubMed ID: 27460211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Helicobacter pylori infection 2013.
    O'Connor A; Molina-Infante J; Gisbert JP; O'Morain C
    Helicobacter; 2013 Sep; 18 Suppl 1():58-65. PubMed ID: 24011247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori-related diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():39-50. PubMed ID: 24160951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Helicobacter pylori.
    Wolle K; Malfertheiner P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Helicobacter pylori infection.
    Costa F; D'Elios MM
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.
    Tay CY; Windsor HM; Thirriot F; Lu W; Conway C; Perkins TT; Marshall BJ
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1076-83. PubMed ID: 23072648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.